AI assistant
Sending…
HARROW, INC. — Director's Dealing 2019
Nov 25, 2019
31774_dirs_2019-11-25_476cd16f-c7b1-4dd9-a31b-f0fba7514ff4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARROW HEALTH, INC. (HROW)
CIK: 0001360214
Period of Report: 2019-11-22
Reporting Person: BOLL ANDREW R. (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-11-22 | Common Stock | X | 39000 | $1.79 | Acquired | 123000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-11-22 | Purchase Warrant | $1.79 | X | 39000 | Disposed | 2019-12-23 | Common Stock (39000) | Direct |
More from HARROW, INC.
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Regulatory Filings
2026
Feb 2
Director's Dealing
2026
Jan 8